PET/MR in the Assessment of Pediatric Histiocytoses: A Comparison to PET/CT. (August 2017)

• Record Type: Journal Article
• Authors: Sher, Andrew C.; Orth, Robert; McClain, Kenneth; Allen, Carl; Hayatghaibi, Shireen; Seghers, Victor
• Is Part Of: Clinical nuclear medicine. Volume 42:Number 8(2017)
• Publication Date: 2017-08
• Subjects: Langerhans cell histiocytosis, pediatric -- LCH -- PET/CT -- PET/MR -- RDD; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000001717
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract : Purpose: The aim of this study was to analyze the feasibility and diagnostic performance of 18 F-FDG PET/MR compared with 18 F-FDG PET/CT in a cohort of pediatric histiocytosis patients with regard to image quality, lesion detection, and FDG quantification. Methods: Children with a diagnosis of Langerhans cell histiocytosis or Rosai-Dorfman disease were prospectively recruited. Seventeen PET/CT and PET/MR examinations were performed on 9 patients (mean age, 6.2 years) following a single-injection dual-imaging protocol. The indication was Langerhans cell histiocytosis in 10 examinations and Rosai-Dorfman disease in 7 examinations. The anonymized data were evaluated for image quality and lesion detection. SUV quantification of each lesion was compared between modalities. Results: All PET/MR examinations had good or excellent image quality and were deemed clinically acceptable. There was substantial agreement of PET image quality among readers of PET/MR images. Per patient, PET/MR and PET/CT had complete concordance in identifying active disease. PET/MRI correctly classified 74 (96%) of 77 foci of disease identified on PET/CT. The per-lesion maximum SUVs were strongly correlated between modalities with a Spearman correlation coefficient of 0.73 ( P < 0.001). Conclusions: The use of PET/MR is clinically feasible in pediatric patients with a histiocytic disease. PET/MR demonstrates comparable image quality and lesion detection to PET/CT while maintaining strongly correlated quantitative performance. Given the significant radiation dose savings, PET/MR represents an appealing alternative to PET/CT in the care of children with histiocytic disorders.